Understanding what causes ovarian cancer to come back after treatment
Official title: Identifying factors associated with ovarian cancer recurrence using a population-based approach
Funded at Emory University · NIH-11211522 · Data updated 2026-11-12
This study is looking at what causes ovarian cancer to come back after treatment, focusing on the genes and other markers that might help predict this, so that women with ovarian cancer can get better, more personalized care in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project start | February 1, 2023 |
| Project end | December 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $248,858 |
| NIH project number | 4R00CA277580-03 |
| Project ID | NIH-11211522 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have been diagnosed with ovarian cancer and are in remission after initial treatment.
✕Less likely to help
Patients who have not been diagnosed with ovarian cancer or those who are currently undergoing treatment may not benefit from this research.
What this research studies
This research investigates the factors that contribute to the recurrence of ovarian cancer after initial treatment. By analyzing gene expression signatures and other biological markers, the study aims to identify distinct characteristics of ovarian cancer that may predict the likelihood of recurrence. Patients who have been diagnosed with ovarian cancer will be the focus, as the research seeks to gather data from a diverse population to enhance the understanding of this disease. The findings could lead to improved prognostic tools and personalized treatment strategies for patients.
Why it matters
Potential benefit: If successful, this research could lead to better predictions of ovarian cancer recurrence, allowing for more tailored and effective treatment plans.
How similar studies have gone: Previous research has shown promise in using gene expression signatures to predict cancer outcomes, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Emory University
Atlanta, United States Active
Researchers
- Principal investigator: Collin, Lindsay Jane — Emory University
- Study coordinator: Collin, Lindsay Jane
Related research
Other NIH-funded projects on the same topics.
-
Why prostate cancer spreads more often in African-American men
Looking at whether a gene called FGFR3 and the cell energy systems (OXPHOS) help explain why prostate cancer spreads more in African-American men.
-
Vaccine to help prevent ovarian cancer from coming back
This vaccine trains Th17 immune cells to help women in first remission from high-grade ovarian cancer stay cancer-free after surgery and chemotherapy.
-
Targeting Hedgehog signaling to improve treatment for ovarian cancer
This study is looking at how a specific pathway in ovarian cancer cells can be targeted to help make treatments work better for patients whose cancer keeps coming back after initial therapies.
-
Improving early detection of ovarian cancer recurrence using MUC16 analysis
This study is working on a new way to detect if high-grade serous ovarian cancer comes back by looking at a specific protein in the blood, which could help doctors catch it earlier and manage treatment better for women facing this condition.
-
Keloid recurrence study using multi-omics in diverse patients
A research effort will look at why keloids come back after surgery, especially in African American patients, using comprehensive molecular data from patient samples.
-
Understanding the experience of ovarian cancer after diagnosis to improve survivorship
This NIH grant funds a mixed-methods study to better understand physical and emotional challenges faced by ovarian cancer survivors and how supportive care can help them live better after diagnosis.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.